The Journal of Pediatrics
Volume 150, Issue 4 , Pages 332-334 , April 2007

Childhood Cancer Cures: The Ongoing Consequences of Successful Treatments

  • Sharon E. Oberfield, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Sharon E. Oberfield, MD, Division of Pediatric Endocrinology, Columbia University, 630 W 168th St, PH 5 East, Room 522, New York, NY 10032.

References 

  1. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae following treatment of medulloblastoma: a prospective study of growth and thyroid function. J Pediatr. 1986;108:219–223
  2. National Cancer Policy BoardWerner SL, Simone JV, Hewitt M. In: Childhood cancer survivorship: improving care and quality of life. Washington, DC: National Academy of Sciences; 2003;p. 32
  3. Oberfield SE, Sklar CA. Endocrine sequelae in survivors of childhood cancer. Adolesc Med. 2002;13:161–170
  4. Oberfield SE, Soranno D, Nirenberg A, Heller G, Allen J, David R, et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Ped Adolesc Med. 1996;150:589–592
  5. Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104:2557–2564
  6. Chin D, Sklar C, Donahue B, Uli N, Geneiser N, Allen J, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer. 1997;80:798–804
  7. Oeffinger K, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–1582
  8. Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, et al. Factors that affect final height and change height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab. 2004;89:4422–4427
  9. Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Negalia JP, et al. Final height and body mass index among adult survivors of childhood brain cancer: Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2003;88:4731–4739
  10. Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab. 2006;91:3494–3498
  11. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Study. J Clin Oncol. 2003;1359–13651;21
  12. Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J Clin Endocrinol Metab. 2006;91:4401–4407
  13. Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robinson LL, et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr. 2007;150:370–375
  14. Bongers ME, Francken AB, Rouwe C, Kamps WA, Postma A. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Pediatr Blood Cancer. 2005;45:139–143
  15. Schriock EA, Schell MJ, Carter M, Hustu O, Ochs JJ. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol. 1991;9:400–405
  16. Birkebaek NH, Fisker S, Clausen N, Tuovinen V, Sindet-Pedersen S, Christiansen JS. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998;30:351–356

PII: S0022-3476(07)00009-1

doi: 10.1016/j.jpeds.2006.12.049

The Journal of Pediatrics
Volume 150, Issue 4 , Pages 332-334 , April 2007

Article Tools